Table 5.

Clinical global impression, by product, measured at the end of each evaluation period

	IqYmune® N = 22	Kiovig® N = 21
Rate of global improvement
1 = Very much improved	0	0
2 = Much improved	3 (13.6)	2 (9.5)
3 = Minimally improved	5 (22.7)	5 (23.8)
4 = No change	12 (54.5)	12 (57.1)
5 = Minimally worse	2 (9.1)	2 (9.5)
6 = Much worse	0	0
7 = Very much worse	0	0

Data are numbers (%) of participants.